NASDAQ: CTNM
Contineum Therapeutics Revenue

Contineum Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CTNM annual revenue was $0.0, with -100% growth year-over-year.

CTNM past revenue growth

How has CTNM's revenue growth performed historically?

Company
-100%
Industry
497.69%
Market
20.68%
CTNM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTNM's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CTNM revenue history

Current Revenue
$0.0
Current Earnings
-$42.3M
Current Profit Margin
0%

Be the first to know when CTNM announces revenue.

CTNM Revenue History By Year

CTNM Yearly RevenueCTNM RevenueCTNM ChangeCTNM Revenue Growth
2024-12-31$0.00-$50.00M-100.00%
2023-12-31$50.00MN/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Contineum Therapeutics Revenue FAQ

What was CTNM's revenue last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Contineum Therapeutics's revenue was $0.00.

What was Contineum Therapeutics's revenue in 2024?

Contineum Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.

How much does Contineum Therapeutics make in a day?

Based on Contineum Therapeutics annual revenue for the past two years, CTNM makes an average of $68,493.15 per day.

What was Contineum Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Contineum Therapeutics's revenue has grown -100% year over year. This is 597.69 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Contineum Therapeutics's revenue in the past year totaled $0.00.

How much does Contineum Therapeutics make in a year?

Contineum Therapeutics's revenue by year for the past two years is:
  • Contineum Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a 100% decrease year over year.
  • Contineum Therapeutics's annual revenue for Dec 31, 2023 was $50.00 million, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.